FLUI.ST WACC - Weighted Average Cost of Capital
The WACC of Fluicell AB (FLUI.ST) is 4.5%.
| Range | Selected | |
| Cost of equity | 4.1% - 6.0% | 5.05% |
| Tax rate | 20.6% - 20.9% | 20.75% |
| Cost of debt | 5.0% - 5.0% | 5% |
| WACC | 4.1% - 5.0% | 4.5% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.32 | 0.41 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 4.1% | 6.0% |
| Tax rate | 20.6% | 20.9% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.0% | 5.0% |
| After-tax WACC | 4.1% | 5.0% |
| Selected WACC | 4.5% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| FLUI.ST | Fluicell AB | 1.19 | 1.42 | 0.73 |
| BRA.WA | Braster SA w restrukturyzacji | 0.66 | 0 | 0 |
| CREO.L | Creo Medical Group PLC | 0.2 | 0.4 | 0.34 |
| DIGN.ST | Dignitana AB | 0.05 | -0.43 | -0.42 |
| IMMNOV.ST | Immunovia AB (publ) | 0.01 | -0.85 | -0.84 |
| INM.WA | Inventionmed SA | 0.08 | 0.42 | 0.39 |
| NN6.DE | Nanorepro AG | 0 | 0.09 | 0.09 |
| NXTMH.HE | Nexstim Oyj | 0.1 | 0.18 | 0.16 |
| SCIB.ST | SciBase Holding AB (publ) | 1.15 | -0.51 | -0.27 |
| SCP.WA | Scope Fluidics SA | 0.01 | -0.03 | -0.02 |
| THRM.V | Therma Bright Inc | 0.01 | 0.05 | 0.05 |
| Low | High | |
| Unlevered beta | 0 | 0.09 |
| Relevered beta | -0.01 | 0.12 |
| Adjusted relevered beta | 0.32 | 0.41 |
FLUI.ST's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for FLUI.ST:
cost_of_equity (5.05%) = risk_free_rate (2.75%) + equity_risk_premium (5.60%) * adjusted_beta (0.32) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.